Nalaganje...
Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia
Patients with acute myeloid leukemia have a very poor prognosis related to a high rate of relapse and drug-related toxicity. The ability of leukemia stem cells (LSCs) to survive chemotherapy is primarily responsible for relapse, and eliminating LSCs is ultimately essential for cure. We developed nov...
Shranjeno v:
| izdano v: | Nanomedicine |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8237247/ https://ncbi.nlm.nih.gov/pubmed/31055076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2019.04.007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|